Publication date: Available online 31 October 2026 Source: American Journal of Kidney Diseases Author(s): Changyuan Yang, Da Chen, Lynne Chepulis, Devika Nair, Priya Vart
Frailty Assessment and Treatment Effects in Clinical Trials of Disease-Modifying Therapies for CKD. // American Journal of Kidney Diseases. – URL: https://www.sciencedirect.com/science/article/pii/S0272638626011868?dgcid=rss_sd_all
Frailty Assessment and Treatment Effects in Clinical Trials of Disease-Modifying Therapies for CKD. American Journal of Kidney Diseases. https://www.sciencedirect.com/science/article/pii/S0272638626011868?dgcid=rss_sd_all
“Frailty Assessment and Treatment Effects in Clinical Trials of Disease-Modifying Therapies for CKD.” American Journal of Kidney Diseases.
@article{article34461,
title = {Frailty Assessment and Treatment Effects in Clinical Trials of Disease-Modifying Therapies for CKD},
journal = {American Journal of Kidney Diseases},
url = {https://www.sciencedirect.com/science/article/pii/S0272638626011868?dgcid=rss_sd_all}
}
ABSTRACT Approximately 5% of patients who develop renal rupture lack an identifiable underlying lesion, such as tumours, hydronephrosis, or vascular malformations. In this case report, we detail a case with a left renal rupture of a...
ABSTRACT Aim Both high and low body mass index (BMI) have been reported to be associated with a higher risk of chronic kidney disease (CKD) progression. However, whether this association varies across CKD stages remains unclear. We...
Nature Reviews Nephrology, Published online: 17 November 2026; doi:10.1038/s41581-026-01151-4 The concept of cardiovascular–kidney–metabolic (CKM) syndrome supports an integrated, multidisciplinary approach to improve patient outcomes....
ABSTRACT Introduction Patients on hemodialysis have an increased risk of sudden cardiac death and an increased cardiac arrhythmia burden due to large fluid and electrolyte shifts, especially during the long inter‐dialytic period....